Real-world effectiveness of asthma biologics by age of initiation and early-childhood risk factors
{{output}}
Background: While several biologics are approved in the U.S. for the treatment of severe asthma in children aged ≥6 years, important knowledge gaps persist regarding their real-world effectiveness. Here, we examine their real-wo... ...
